Status:

TERMINATED

Treatment of Wounds Utilizing Light

Lead Sponsor:

QRay Ltd.

Conditions:

Diabetic Ulcer

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The Qray device is emitting broad light energy that is intended for diabetic ulcer healing. The study is double blinded.

Eligibility Criteria

Inclusion

  • Patient has 8 weeks venus leg ulcer.
  • The ulcer was not better on prior treatment of various medical clinics.
  • The patient has diabetic ulcer grade 1 or 2

Exclusion

  • Patient has severe infection.
  • Patient is taking antibiotic
  • Patient has ankle brachial index less than 0.7
  • Patient is schedule to undergone revascularization surgery 10 weeks before the study
  • Patient has photosensitive disease
  • Patient has cancer
  • Creatinine level is more than 2 mg%
  • Patient is taking immunosuppressive medication.
  • Pregnant women
  • Dialysis patient
  • Anaemic patients(less than 9 gr)
  • Patient has Albumin level less than 3 mg%

Key Trial Info

Start Date :

August 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2010

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00634868

Start Date

August 1 2008

End Date

December 1 2010

Last Update

June 10 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Soroka Medical Center

Beersheba, Israel